Your browser doesn't support javascript.
loading
CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals.
Simrén, Joel; Brum, Wagner S; Ashton, Nicholas J; Benedet, Andrea L; Karikari, Thomas K; Kvartsberg, Hlin; Sjons, Emma; Lussier, Firoza Z; Chamoun, Mira; Stevenson, Jenna; Hopewell, Robert; Pallen, Vanessa; Ye, Keqiang; Pascoal, Tharick A; Zetterberg, Henrik; Rosa-Neto, Pedro; Blennow, Kaj.
Afiliação
  • Simrén J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. joel.simren@gu.se.
  • Brum WS; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden. joel.simren@gu.se.
  • Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Benedet AL; Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
  • Karikari TK; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Kvartsberg H; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Sjons E; Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, London, UK.
  • Lussier FZ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Chamoun M; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Ouest-de-l'Île-de-Montréal; Department of Neurology and Neurosur
  • Stevenson J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Hopewell R; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
  • Pallen V; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Ye K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Pascoal TA; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Rosa-Neto P; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Ouest-de-l'Île-de-Montréal; Department of Neurology and Neurosur
  • Blennow K; Montreal Neurological Institute, Montreal, QC, Canada.
Alzheimers Res Ther ; 14(1): 192, 2022 12 22.
Article em En | MEDLINE | ID: mdl-36544221

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas tau / Neocórtex / Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas tau / Neocórtex / Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia